Filtros de búsqueda

Lista de obras de Finn Sellebjerg

A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod

artículo científico publicado en 2016

A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis

scientific article published on 01 March 2005

A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations

artículo científico publicado en 2000

A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis

artículo científico publicado en 2009

Absence of systemic oxidative stress and increased CSF prostaglandin F2α in progressive MS.

artículo científico publicado en 2016

Acute optic neuritis: myelin basic protein and proteolipid protein antibodies, affinity, and the HLA system

scientific article published on 01 December 1995

Alcohol consumption in adolescence is associated with a lower risk of multiple sclerosis in a Danish cohort

scientific article published on 20 August 2018

Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655.

artículo científico publicado en 2011

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

artículo científico publicado en 2013

Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis

scientific article published on 01 March 2020

Anti-myelin basic protein and anti-proteolipid protein antibody-secreting cells in the cerebrospinal fluid of patients with acute optic neuritis

artículo científico publicado en 1994

Association between age at onset of multiple sclerosis and vitamin D level-related factors

artículo científico publicado en 2015

Author response: Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark

artículo científico publicado en 2019

Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP

artículo científico publicado en 2008

B cells from patients with multiple sclerosis have a pathogenic phenotype and increased LTα and TGFβ1 response

artículo científico publicado en 2018

Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis

artículo científico publicado en 2013

Bone microarchitecture and bone mineral density in multiple sclerosis.

artículo científico publicado en 2017

Breakthrough disease during interferon-[beta] therapy in MS: No signs of impaired biologic response

artículo científico publicado en 2010

Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS

artículo científico publicado en 2019

CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.

artículo científico publicado en 2001

CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis

scientific article published on 01 January 2000

CD26 + CD4 + T cell counts and attack risk in interferon-treated multiple sclerosis

artículo científico publicado en 2005

CD4 T cell activation and disease activity at onset of multiple sclerosis.

artículo científico publicado en 2004

CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis

artículo científico publicado en 2006

CD8+ T cell activation correlates with disease activity in clinically isolated syndromes and is regulated by interferon-beta treatment.

artículo científico publicado en 2006

CLIPPERS among patients diagnosed with non-specific CNS neuroinflammatory diseases

artículo científico publicado en 2014

CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis

artículo científico publicado en 2012

CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage

artículo científico publicado en 2018

CSF proteome in multiple sclerosis subtypes related to brain lesion transcriptomes

artículo científico publicado en 2021

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

artículo científico publicado en 2012

Cerebral metabolism, magnetic resonance spectroscopy and cognitive dysfunction in early multiple sclerosis: an exploratory study

artículo científico publicado en 2012

Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.

artículo científico publicado en 2010

Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis.

artículo científico publicado en 2016

Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis

scientific article published on 19 February 2015

Cerebrospinal fluid measures of disease activity in patients with multiple sclerosis

artículo científico publicado en 1998

Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis

scientific article published on 17 August 2015

Changes in the retinal veins in acute optic neuritis

artículo científico publicado en 1999

Characterization of naïve, memory and effector T cells in progressive multiple sclerosis.

artículo científico publicado en 2017

Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis

artículo científico publicado en 2004

Chemokine receptor CCR5 in interferon-treated multiple sclerosis

artículo científico publicado en 2007

Chemokine receptor expression on B cells and effect of interferon-beta in multiple sclerosis

artículo científico publicado en 2002

Chemokine receptors on mononuclear phagocytes in the central nervous system of patients with multiple sclerosis

scientific article published on 01 January 2002

Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis.

artículo científico publicado en 2001

Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system.

artículo científico publicado en 2003

Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis

artículo científico publicado en 2012

Clinical relevance of brain volume measures in multiple sclerosis

artículo científico publicado en 2014

Clinical utility of anti-MOG antibody testing in a Danish cohort

artículo científico publicado en 2018

Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab

artículo científico publicado en 2013

Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study

artículo científico publicado en 2019

Correction: Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression

artículo científico publicado en 2013

Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients.

artículo científico publicado en 2012

Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients

artículo científico publicado en 2016

Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-beta1b

artículo científico publicado en 2005

Cytokines and soluble IL-4 in patients with acute optic neuritis and multiple sclerosis

artículo científico publicado en 1997

Defining active progressive multiple sclerosis

artículo científico publicado en 2017

Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study

artículo científico publicado en 2018

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

artículo científico publicado en 2019

Diagnostic Value of Oligoclonal Bands in Children: A Nationwide Population-Based Cohort Study

scientific article published on 13 March 2019

Differential microRNA expression in blood in multiple sclerosis.

artículo científico publicado en 2013

Dimethyl fumarate therapy reduces memory T cells and the CNS migration potential in patients with multiple sclerosis

scientific article published on 16 October 2019

Dimethyl fumarate therapy suppresses B cell responses and follicular helper T cells in relapsing-remitting multiple sclerosis

scientific article published on 25 July 2018

Disease protection and interleukin-10 induction by endogenous interferon-β in multiple sclerosis?

artículo científico

Distinct chemokine receptor and cytokine expression profile in secondary progressive MS

artículo científico publicado en 2001

Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS

artículo científico publicado en 1998

Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.

artículo científico publicado en 2006

Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease

artículo científico publicado en 2019

Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.

artículo científico publicado en 2013

Early safety and efficacy of fingolimod treatment in Denmark.

artículo científico publicado en 2016

Effect of natalizumab on circulating CD4+ T-cells in multiple sclerosis

artículo científico publicado en 2012

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.

artículo científico publicado en 2018

Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β

artículo científico publicado en 2019

Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study

artículo científico publicado en 2009

Endogenous and recombinant type I interferons and disease activity in multiple sclerosis

scientific article (publication date: 2012)

Endogenous interferon-β-inducible gene expression and interferon-β-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis.

artículo científico publicado en 2015

Evidence favoring the involvement of CC chemokine receptor (CCR) 5 in T-lymphocyte accumulation in optic neuritis

artículo científico publicado en 2003

Expansion of CD5 - B cells in multiple sclerosis correlates with CD80 (B7-1) expression

artículo científico publicado en 2002

Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis

artículo científico publicado en 2016

Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis

artículo científico publicado en 2019

FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis

artículo científico publicado en 2012

FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS

scientific article published on 16 February 2014

Functional neuroimaging of recovery from motor conversion disorder: A case report

artículo científico publicado en 2018

GPR15+ T cells are Th17 like, increased in smokers and associated with multiple sclerosis

artículo científico publicado en 2018

Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis.

artículo científico publicado en 2003

Gene expression analysis of interferon-beta treatment in multiple sclerosis

artículo científico publicado en 2008

Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis

artículo científico publicado en 2013

Genetic and environmental determinants of 25-hydroxyvitamin D levels in multiple sclerosis

Genetic burden of MS risk variants distinguish patients from healthy individuals but are not associated with disease activity.

artículo científico publicado en 2017

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

artículo científico publicado en 2011

Genetic variants are major determinants of CSF antibody levels in multiple sclerosis

artículo científico publicado en 2015

HLA DRB1*1501 and intrathecal inflammation in multiple sclerosis

scientific article published on 01 April 2000

High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial

artículo científico publicado en 2016

Human pegivirus detected in a patient with severe encephalitis using a metagenomic pan-virus array

artículo científico publicado en 2016

IL-6, IL-12, and IL-23 STAT-Pathway Genetic Risk and Responsiveness of Lymphocytes in Patients with Multiple Sclerosis

artículo científico publicado en 2019

Identification of Suitable Reference Genes for Peripheral Blood Mononuclear Cell Subset Studies in Multiple Sclerosis.

artículo científico publicado en 2015

Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation.

artículo científico publicado en 2009

Illegal cannabis use is common among Danes with multiple sclerosis

artículo científico publicado en 2019

Immunological effects of methylprednisolone pulse treatment in progressive multiple sclerosis.

artículo científico publicado en 2014

Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis

artículo científico publicado en 2000

Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008‒2018: A nationwide, population-based cohort study

scientific article published on 05 June 2019

Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression

artículo científico publicado en 2008

Increased T cell expression of CD154 (CD40-ligand) in multiple sclerosis

artículo científico publicado en 2001

Increased cerebrospinal fluid chitinase 3-like 1 and neurofilament light chain in pediatric acquired demyelinating syndromes

scientific article published on 11 June 2018

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.

artículo científico publicado en 2009

Inflammatory markers of CHMP2B-mediated frontotemporal dementia

artículo científico publicado en 2018

Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production

artículo científico publicado en 2010

Interleukin-2 effect on T cell activation revealed by daclizumab treatment

artículo científico publicado en 2011

Interleukin-8 in cerebrospinal fluid from patients with septic and aseptic meningitis

artículo científico publicado en 1996

Intrathecal IgG synthesis and autoantibody-secreting cells in multiple sclerosis

artículo científico publicado en 2000

Intrathecal synthesis of free immunoglobulin light chains in multiple sclerosis

scientific article published on 01 September 1998

Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination

artículo científico publicado en 2016

Low frequency and rare coding variation contributes to multiple sclerosis risk

MAIT cell subtypes in multiple sclerosis

scientific article published on 20 November 2019

MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis

MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis

artículo científico publicado en 1998

Mapping grip-force related brain activity after a fatiguing motor task in multiple sclerosis

artículo científico publicado en 2022

Methylprednisolone does not restore biological response in multiple sclerosis patients with neutralizing antibodies against interferon-β.

artículo científico publicado en 2009

Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.

artículo científico publicado en 2016

Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies

artículo científico publicado en 2016

Multiple sclerosis--the significance of genes. The Danish Society of Neurology

artículo científico publicado en 2008

Multiple sclerosis: A clinically useful genetic variant in multiple sclerosis?

artículo científico publicado en 2015

Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system

artículo científico publicado en 2002

Myelin Basic Protein-Induced Production of Tumor Necrosis Factor-α and Interleukin-6, and Presentation of the Immunodominant Peptide MBP85-99 by B Cells from Patients with Relapsing-Remitting Multiple Sclerosis

artículo científico publicado en 2016

Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial

artículo científico publicado en 2014

Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark

scholarly article by Viktoria Papp et al published 9 November 2018 in Neurology

Neurofilament in CSF-A biomarker of disease activity and long-term prognosis in multiple sclerosis

artículo científico publicado en 2016

Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report

artículo científico publicado en 2007

Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab

scientific article published on 20 April 2011

Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general

scholarly article by Marte W. Gustavsen et al published September 2014 in Journal of Neuroimmunology

Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles

artículo científico publicado en 2013

Onset symptoms in paediatric multiple sclerosis

article published in 2014

Optic neuritis: chemokine receptor CXCR3 and its ligands.

artículo científico publicado en 2004

Oral fumarate for relapsing-remitting multiple sclerosis.

artículo científico publicado en 2008

Orthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes

artículo científico publicado en 2018

Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis

artículo científico publicado en 2010

Peptide specificity of anti-myelin basic protein antibodies in patients with acute optic neuritis and the HLA system

artículo científico publicado en 1994

Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation

artículo científico publicado en 2019

Prediction of antibody persistency from antibody titres to natalizumab

scientific article published on 27 March 2012

Prediction of natalizumab anti-drug antibodies persistency.

artículo científico publicado en 2018

Prediction of response to interferon therapy in multiple sclerosis

scientific article published on 18 June 2014

Preserved in vivo response to interferon-alpha in multiple sclerosis patients with neutralising antibodies against interferon-beta (REPAIR study).

artículo científico

Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis

scientific article published on 16 August 2018

Progression and CSF Inflammation after Eradication of Oligoclonal Bands in an MS Patient Treated with Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma.

artículo científico publicado en 2012

Progressive multiple sclerosis, cognitive function, and quality of life.

artículo científico publicado en 2018

Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis

artículo científico publicado en 2019

Qualitative assessment of intrathecal IgG synthesis by isoelectric focusing and immunodetection: interlaboratory reproducibility and interobserver agreement.

artículo científico publicado en 1996

RGMA and IL21R show association with experimental inflammation and multiple sclerosis

article

Recovery from an acute relapse is associated with changes in motor resting-state connectivity in multiple sclerosis

artículo científico publicado en 2015

Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients

artículo científico publicado en 2014

Relationship between Multiple Sclerosis-Associated IL2RA Risk Allele Variants and Circulating T Cell Phenotypes in Healthy Genotype-Selected Controls

scientific article published on 25 June 2019

Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis

artículo científico publicado en 2013

Relationship between soluble CD25 and gene expression in healthy individuals and patients with multiple sclerosis.

artículo científico publicado en 2017

Residual symptoms and signs after untreated acute optic neuritis. A one-year follow-up

artículo científico publicado en 1997

Responsiveness of the Multiple Sclerosis Impairment Scale in comparison with the Expanded Disability Status Scale

artículo científico publicado en 2005

Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry.

artículo científico publicado en 2015

Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease.

artículo científico publicado en 2016

Selective suppression of chemokine receptor CXCR3 expression by interferon-beta1a in multiple sclerosis

scientific article published on 01 April 2002

Serum neurofilament light as a biomarker in progressive multiple sclerosis

artículo científico publicado en 2020

Serum neurofilament light chain in healthy elderly and in patients with age-related macular degeneration

scientific article published on 10 October 2019

Shift work at young age is associated with increased risk of multiple sclerosis in a Danish population

artículo científico publicado en 2016

Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.

artículo científico publicado en 2011

Smoking affects the interferon beta treatment response in multiple sclerosis

artículo científico publicado en 2018

Smoking reduces circulating CD26hiCD161hi MAIT cells in healthy individuals and patients with multiple sclerosis.

artículo científico publicado en 2017

Soluble ICAM-1, demyelination, and inflammation in multiple sclerosis and acute optic neuritis.

artículo científico publicado en 1998

Structural and cognitive correlates of fatigue in progressive multiple sclerosis

artículo científico publicado en 2018

Systemic T-cell activation in acute clinically isolated optic neuritis

scientific article published on 01 May 2005

Systemic frequencies of T helper 1 and T helper 17 cells in patients with age-related macular degeneration: A case-control study

artículo científico publicado en 2017

Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression

artículo científico publicado en 2013

Tetranectin in cerebrospinal fluid of patients with multiple sclerosis.

artículo científico publicado en 2006

Tetranectin in cerebrospinal fluid: biochemical characterisation and evidence of intrathecal synthesis or selective uptake into CSF

artículo científico publicado en 2005

The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis

artículo científico publicado en 2016

The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility

scholarly article published 13 July 2017

The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis

artículo científico publicado en 2008

The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers.

artículo científico publicado en 2009

The etiology of multiple sclerosis: genetic evidence for the involvement of the human endogenous retrovirus HERV-Fc1

artículo científico publicado en 2011

The interaction between smoking and HLA genes in multiple sclerosis: replication and refinement

artículo científico publicado en 2017

The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis

The transcriptome of peripheral blood mononuclear cells in patients with clinical subtypes of late age-related macular degeneration

scientific article published on 15 August 2019

Therapeutic interference with leukocyte recirculation in multiple sclerosis.

artículo científico publicado en 2015

Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS

scientific article published on 04 November 2020

Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect

artículo científico publicado en 2015

Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab

artículo científico publicado en 2016

[Biological treatment of multiple sclerosis]

artículo científico publicado en 2008

[IGG index or oligoclonal bands in the diagnosis of disseminated sclerosis]

scientific article published on 01 February 1993

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda